Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Prophylaxis in High-Risk Pregnancies Requiring Cerclage
NCT07608562Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in Cervical insufficiency (CI), sponsored by Wake Forest University Health Sciences. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
Cervical insufficiency (CI)
Beyond the preview
Go deeper on NCT07608562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608562.